OMEICOS Therapeutics Shows OMT-28`s Phase 2 Potential in PMD
29 Jan 2026 //
GLOBENEWSWIRE
OMEICOS Completes Enrollment Of PMD-OPTION Study
26 Sep 2024 //
GLOBENEWSWIRE
OMEICOS`s Announces First-Dosing in Ph2 Clinical Study Evaluating its OMT-28
29 Apr 2019 //
BUSINESSWIRE

Market Place
Sourcing Support